A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

Clinical trial NCT04998331 · COMPLETED

Trial details

NCT number: NCT04998331
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Hodgkin Disease Lymphoma, T-Cell, Cutaneous

Start date: 2021-10-29
Primary completion: 2022-04-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.